Healthcare & Life Sciences in the U.S. – Outlook 2025
The Bounce Back: Unlocking the Healthcare and Life Science Industry’s Potential in a Time of Change
-
janvier 20, 2025
Downloads
Download Report
-
In the fourth edition of FTI Consulting’s U.S. Healthcare and Life Sciences Outlook Survey, healthcare and biopharmaceutical organizations are embracing a new sense of optimism. This is a significant finding given the immense change over the past 12 months — Republicans taking control of both the United States executive and legislative branches of government and increasing use of artificial intelligence (“AI”) in drug discovery and development — and challenges affecting not only their businesses but the world in which they operate, including drug pricing concerns and continued geopolitical tensions across the globe, just to name a few.
Click here to download the full Healthcare & Life Sciences in the U.S. – Outlook 2025 report
Related Insights
Published
janvier 20, 2025
Key Contacts
Senior Managing Director, Head of Americas Healthcare & Life Sciences
Senior Managing Director
Senior Managing Director
Senior Managing Director